Volume 28, Number 1—January 2022
Research
High-Level Quinolone-Resistant Haemophilus haemolyticus in Pediatric Patient with No History of Quinolone Exposure
Table 2
Characteristics | 2019-19 | GTC 14202T | GTC 15009T |
---|---|---|---|
V-factor requirement | + | + | + |
X-factor requirement | + | + | + |
Indole production | + | + | - |
Urease | + | + | + |
Lipase | – | – | – |
Ornithine decarboxylase | – | – | – |
Alkaline phosphatase | + | + | + |
Proline arylamidase | – | – | – |
β-galactisidase | – | – | – |
γ‐glutamyltransferase | – | – | – |
Acid source | |||
D-glucose | + | + | + |
D-fructose | + | + | + |
Maltose | – | – | + |
Sucrose | – | – | – |
Growth temperature | |||
4°C | – | – | – |
16°C | – | – | – |
25°C | – | W | – |
37°C | ++ | ++ | ++ |
42°C | – | – | – |
CO2 enhances growth | – | – | – |
Hemolysis | – | – | + |
*W, weak; –, negative; + positive.
1These authors contributed equally to this article.
Page created: November 10, 2021
Page updated: December 22, 2021
Page reviewed: December 22, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.